Term
|
Definition
Most common form is essential HTN
Isolated systolic HTN: Loss of elasticity of aorta as you age->only increases systolic BP->large pulse pressure of up to 100 (normal=40)->heart requires more O2 but its ability to obtain O2 has deceased, no drugs can help it, doubles risk of death due to CHD
African Americans: Higher prevalence of HTN, a volume dependent HTN rather than vasoconstrictive HTN with high plasma renin like caucasians; Use thiazide diuretic or combo w/ ACE-I, NOT ACE-I alone b/c renin is already low
Normal BP: <120/<80
Pre-HTN: 120-139/80-89; Can use non-pharmacological intervention if patient doesn't have other condtiions
Stage 1 HTN: 140-159/90-99; 1 drug
Stge 2 HTN: 160+/100+; 2 drugs
Drugs:
Diuretics: Thiazide (HTN)-almost always used in combos, Loop Diuretics (HF), K+ Sparing (resistant HTN)
B-Blockers: Not 1st line, Atenolol most common
Alpha-Beta Blockers: HF, not HTN; Carvediol most important
Ca-Channel Blockers: Amlidopine-t1/2=40 hours
Renin-Angiotensin-Aldosterone blockers: Catopril frequently used for HTN
Central Sympatholytics: Alpha-Methyldopa=only drug for HTN treatment in pregant women; Resperine-acts in periphery ("resperiphery"), not CNS
Less than 50% have BP under control b/c: Bad Dosing (BP highest early morning, but drugs dosed 1x/day only last until night), bad combos (ex: B-blocker and ACE-I: B-blocker inhibits renin release->ACE-I has nothing to do), non-compliance, systolic BP is hard to control |
|
|
Term
|
Definition
Vasomotor Center in CNS (Alpha 2 agonists):
Alpha-Methyldopa: Prodrug converted to methyldopamine then methylnorepinephrine; Only anti-HTN for pregnancy; Acts on post-synaptic alpha-2A receptors in CNS
Alpha-2A: Inhibitory, CNS and periphery, limits SNS output, located pre-synaptically in the periphery
Alpha-2B: In vasculature, cause vasoconstriction
Clonidine: Oral only(IV could cause BP rise from alpha-2B); Rebound HTN common; Increased effect with increased dose
Sympathetic (Peripheral) Ganglia:
Trimethaphan: Intolerable SE's for HTN from blocking PNS so not used except in hypertensive crisis
Sympathetic Nerve Terminals:
Resperine: Inhibits VMAT->Prevents DA uptake->Can't be converted to NE; SE=Depression so rarely used
Receptor Blockers:
Beta Blockers: Inhibit B-1 effects on heart, decrease renin release
Alpha Blockers: Non-selective ones cause Orthostatic HTN and can't be used for HT, only used for pheochromocytomas; Selective ones like prazosin and doxazosin (selective for alpha-1) can be used for HTN and improve lipid profile, but may cause HF (ALLHAT study)->Not 1st line, too powerful |
|
|
Term
|
Definition
Depress renal function->Increase diuresis (urine volume) and natriuresis (Na excretion)
Long term effects are due to arterial dialation over time (no one knows why)
Thiazide and Thiazide-like: Hydrochlorothiazide (HCTZ), Chlorthalidone, Metolazone, Indapamide
Loop Diuretics: Furosemide, Torsemide
K+Sparing epithelial channel blockers: Amiloride, Triamterene ("Block AT Epithelial channels)
K+Sparing aldosterone antagonists: Spironolactone, Eplerenone
Osmotic Diuretic: Mannitol
Carbonic Anhydrase inhibitor: Acetazolamide
Path through a Nephron:
Bowman's Capsule
->PCT: Mannitol (also works a little in TAL), Acetazolamide; Na+/H+ exchanger, 65% of sodium absorbed; Carbonic Anhydrase helps form carbonic acid (H2CO3), which dissociates into HCO3- that gets reabsorbed and helps sodium reabsorption; so early that renal tubule can compensate if Na+ absorption stopped here (weak diuretics act here)
Acetozolamid: Decreases reabsorption of Na+ through Carbonic Anhydrase Inhibition; More base in urine->acidosis; NaCl reabsorption increased as a response->hyperchloremia; Treats glaucoma and mountain sickness, not HTN
->Proximal Straight tubule
->Thick Ascending Limb (part of LOH): Loop Diuretics (esp Furosemide, also Torsemide; Used in HF, too powerful for HTN), 25% Na+ reabsorbed, Impremeable to H20, Na+/K+/2Cl- co-transporter out of the cell allows hyperosmolar zone to pull water out of collecting duct
->Macula Densa: Early Part of DCT, COX2 in macula densa cells sense low Na+ and produce prostaglandins->communicates with JG cells in afferent arteriole->Gs->cAMP->renin, Furosemides cause this to happen (bad)
->Distal Convoluted Tubule: Thiazides, Impermeable to H20, Na/Cl cotransporter (Thiazides inhibit), Na/Ca exchanger controlled by PTH that brings Na inside (lower sodium, higher Ca reabsorption->Thiazides cause excess Ca reabsorption->not for kidney stone patients, good for osteoporosis), 10% of Na+ and Cl-reabsorption
->Collecting Tubule and duct: K+Sparring aldosterone antagonists (weak on their own, used in combo w/ HCTZ), K+Sparring Epithelial Channel Diuretics (also work a little at DCT, directly block luminal side sodium channel to decrease reabsorption, can be used as monotherapy); aldosterone sensitive Na+/K+ exchanger results in Na+ reabsorption and K+ secretion->High aldosterone activity results in hypoalkemia; ADH pulls water out into hyperosmotic zone
Hyperkalemia: K+ sparring, Hypokalemia: all others
HyperCalcemia: Thiazide Diurectics, HypoCalcemia: Loop Diuretics
Alkalosis: Loop Diuretics, Thiazide
Acidosis: K+ sparing, Carbonic anhydrase inhibiting |
|
|
Term
|
Definition
Increased K+ secretion->HypoKalemia (Loop Diuretics cause Hypokalemia too)
Anelgesic Aspirin Dose: Decreases thiazide effectiveness (from decreasing PG's); NSAID's have interactions w/ every antihypertensive except Ca+ Channel Blockers
Hydrochlorothiazide: Most commonly prescribed
Chlorthalidone: Best (t1/2=50-60 hours), should be most common
Metolazone: Can be used with poor renal function
Indapamide: Ineffective in lowering BP in systolic HTN
Use for: HTN (50mg dose), HF (only if patient becomes resistant to loop diuretic), Nephrolithiasis due to idiopathic hypercalciuria (kidney stones from too much Calcium in urine), Nephrogenic diabetes insipidus-can't concentrate urine b/c kidney doesn't respond to ADH (thiazides cause water retention in this case!)
SE: Hypokalemia, Hyponatremia, HyperGLUC (Glucose, Lipidemia, Urecemia, Calcemia)
Drug interactions: NSAIDS, Lithium-blood level increases w/ thiazides, Quinidine-prolongs QT interval (anti-arrhythmic) which increases the effect of hypokalemia prolonging QT interval->Torsades, Digitalis (digoxin)-hypokalemia from thiazides causes excessive inhibition of Na/K pump in the heart->arrhythmias |
|
|
Term
RAAS Drugs: ACE Inhibitors |
|
Definition
Can treat both HTN and HF as 1st line
RAAS drugs: ACE Inhibitors, Angiotension Receptor blockers (ARB's), and direct renin inhibitor.
ACE'I's ("pril's"): Catopril (prototype), lisinopril (top prescribed), enalapril, ramapril
You get: Build up of Ang I, Build up of renin (no negative feedback from ang II to stop making renin), decreased Ang II->less vasoconstriciton->decreased TPR->decreased BP and less aldosterone relese->less aldosterone release leads to less water retention, Increased kinins->bradykinins->vasodilation and NO production (Cough!), Increaed K+ level (don't combine with potassium sparing drug->even more hyperkalemia->heart block) and Decreased Na+ (from decreased aldosterone)
NO BARORECEPTOR REFLEX->No increase in HR or CO (ang II normally increases SNS but now it can't->cancels out sympathetic compensation from baroreceptors->No change in catecholamines)
Drugs ("prils")(mechanism of action same for all):
Captopril: Prototype, Administered in active form->quick onset and short t1/2; Greatest efficacy on empty stomach
Enalapril: Pro-drug with longer onset of action and t1/2
Enalaprilat: Active metabolite of enalapril; Comes in IV form in hypertensive crisis
Lisinopril: Not a pro-drug, but has a t1/2 of 11 hours
Ramipril: HOPE study-Less mortality and morbidity in patients with cardiovascular disease
SE's: No orthostatic hypotension (b/c no effect on veins); dose related loss of taste, neutropenia; Cough; angioneurotic edema; Hyperkalemia; Hypotension
Low Na+ diet enhances effects
African Americans: ACE-I's don't work as well, bigger age-related treatment difference
Use: 1st line in stage 1 HTN in non-african americans; people with HTN and HF, patients with LVH, patients with HTN with diabetes
Don't use with: Poor renal function, bilateral renal artery stenosis (Ang II constricts efferent arteriole to increase GFR and this is needed in renal failure/renal stenosis patients)
Some Ang II can still be made through alternative pathway (ang I to ang II via chymase)
|
|
|
Term
Angiotensin II Receptor Blockers (ARB's) |
|
Definition
Blocks binding of Angiotensin II to AT1 receptors (completely blocks Ang II effects unlike ACE I's); possibly increases Ang II binding at AT2 receptors->vasodilation
NO bradykinin effect->No cough or angioedema
Equal efficacy to ACE-I's
Drugs ("Sartans")
Losartan: Prototype, t1/2=2 hours, but active metabolite has t1/2=6-9 hours
Valsartan: Food effect-most effective on empty stomach
Telmisartan: Longest t1/2, 24 hours
Asilsartan: Newest ARB, may not have additional benefits |
|
|
Term
|
Definition
Aliskiren: Binds renin, t1/2=24 hours
Renin may or may not contribute HTN, effectiveness unknown
None of the ACE-I SE's (like ARB's) |
|
|
Term
|
Definition
Block L-ype Ca channel
Use dependent: stronger effect with increasing frequency of stimulation
Non-DHP's: Dilitazem and Verapamil; Least selective-affect both arterioles and heart-slow HR and decreases contractility, slows conduction through SA and AV nodes, impairs muscle contraction via inhibiting actin-myosin cross bridge formation
DHP's ("AN DHP"): Nimidopine and amlodipine; Selective for arterioles
Clevidipine: short acting, t1/2=10 mins, IV for HTN emergencies
Verapamil: Relaxes smooth muscle in GI tract->constipation, Interacts with digoxin (blocks its efflux pump)
Nifedipine: Short acting, sympathetic surge->MI
Amiodipine: Long t1/2 from slow hepatic degradation, high bioavailability (no 1st pass effect like others), doesn't cause baroreceptor reflex and SNS surge like the others that could lead to MI; Peripheral Edema (unrelated to kidneys so diuretics won't counteract this effect), equivalent to clorthalodone in ALLHAT study
Use for: HTN (as monotherapy or combo), Angina, Cardiac Arrhythmias (non-DHP's for a-fib and a-flutter), NOT HF (causes cardiac depression)
Advantages: Effective in isolated systolic HTN (b/c they can increase compliance of large arteries), no tolerance from renal fluid retention, no increased renin release, don't effect lipid or glucose metabolism (like thiazides or B blockers), no effect on postural HTN, don't interact with NSAIDS |
|
|
Term
|
Definition
3rd line for HTN
Decrease renin release b/c JG cells use B1 receptors
Propanolol: 1st gen, non-selective, interact w/ NSAID's (block PG synthesis which is how B blockers work)
Atenolol, Metoprolol, Esmolol: 2nd gen, B1 cardioselective, decrease in HR and CO (lower MAP) causes decreased BP-MAPxTPR=BP (TPR actually increases->initially no decreased BP b/c of this, but then TPR decreases and BP can derease)
Atenolol: Used for HTN, short t1/2->dangerously high morning BP
Metoprolol: Used for Angina
Esmolol: Quick onset, short t1/2, IV during anesthesia to relieve hyperactive SNS that causes arrhythmias
Pindolol: 3rd gen, Beta blocker with intrinsic sympathomimetic activity; Partial agonist of Beta 1 receptor with 30% of NE's activity->increases HR a little, but not as much as NE; Used for treating HTN in patients with HR <45
Labetalol, Carvedilol: 4th gen, Beta blockers with alpha blocking or vasodilating effects, decreases TPR
Labetalol: Blocks B1 and B2 5x less than alpha 1 receptor; Used for resistant HTN
Carvedilol: Used for HF; Blocks B1, B2, and alpha 1 equally; Anti-oxidant and anti-inflammatory; Dialates veins->orthostatic HTN
Nebvilolol: Newest, Most selective B1 blocker, HTN in asthma patients; Anti-oxidant and vasodilator, less SE's
SE's: CNS effects, CHF, Bronchospasm, Metabolic effects: Inuslin insensitivity and hyperglycemia->DM, Raise TG and lower HDL
The ones that are most lipid soluble are metabolized by liver, least lipid soluble are metabolized by kidney
Use for: MI and HTN, angina and HTN, heart failure and HTN; Not 1st line for just HTN
Associated with higher incidence of stroke (high BP variability) |
|
|
Term
Direct Arterial Vasodilators |
|
Definition
Hydralazine: Selective for arterioles; Short acting
Minoxidil: K+-ATP Channel Opener->Vasodilation of arterioles, Rogaine
Nitroprusside: Serves as a source of NO to dilate venules and arterioles (venules best); Used in hypertensive emergency; Cyanide toxicity
Sildenafil |
|
|
Term
|
Definition
Starting at 115/75, each 20/10mmHg increase in BP doubles CV risk independent of other risk factors
Complicated HTN: Patients w/ diabetes or kidney disease; Should start pharmacological therapy at 130/80
Uncomplicated HTN: Pharmacological therapy started at 140/90
Resistant HTN: HTN above 140/90 on Three drugs->Add a 4th drug like minoxidil (direct arteriole vasodilator) or labedolol (Beta-blocker with orthostatic hypotension from alpha-1 antagonist properties) (both have high SE's)
To make a HTN diagnosis, only one of sysolic and diastolic needs to be in the criterions range for the stage
HF w/ low EF (30%)->ARB and ACEi regardless if they're hypertensive
HF and HTN->Patient should be on B-Blocker (1/10th dose)
Patient with DM->ACEi and ARB regardles if they're hypertensive to protect the kidney
Two drug therapy: Recommended that one is a thiazide type diuretic
HTN: Asymptomatic at first
Pseudoresistance: Due to inaccurate measurement, patient non-adherence, high Na intake, concurrent NSAID, psychotropic (SSRI), or cocaine, suboptimal regimen for patient
True resistance: Rare, must rule out renal disease, renal artery stenosis, pheochromocytoma, primary aldosterone disease
Diuretics: Good-least expensive; if one doesn't work, try another; Bad-Can intice Type II DM
Beta-Blockers: Good-Effective in combos with Thiazide, Useful in patients with heart disease; Bad-Blocks B2 receptors on pancreatic islet insulin cells->difficult to use in DM; Carvedilol, nebivolol, and labetolol best
ACE-I's: Good-Effective; Have additional benefit with DM, renal, and cardiac diseases; Have antiatherosclerotic effect; Bad-Cough, not as effective in African Americans
ARB's: Good-Effective, benign SE's, protect diabetic kidney; Bad-Expensive: patent protected except Losartan
Ca channel blockers: Good-Effetive, well-tolerated, widely used, only decrease HTN nothing else (could be a bad thing if you want other stuff to happen)
Others: Aldosterone antagonist, central adrenergic inhibitors like clonidine and methyldopa (pregnancy-magnesium can also be used); Clonidine-rebound effect; Alpha receptor blockers-Used for men with BPH; Direct vasodilators: hydralazine, minoxidil, nitroprusside; Renin inhibitors: Aliskirin
Bad combos: ACE Inhibitor + B Blocker (ACE Inhibitor has nothing to do), ACE Inhibitor + K+ Sparing diuretic (hyperkalemia), Non-DHP Ca Channel Blocker + B Blocker (synergistic in lowering HR)
|
|
|